Issues with deployment and scaling are the real barriers holding back healthcare AI from delivering value, according to leaders at AI companies Nvidia and Hoppr. That’s why they’re shifting their
CEO of For-Profit MA Plan Tells CMS “Pay Us Less”
It’s a journalist’s dream to interview articulate, sincere, no-holds-barred CEOs. When they actually create headlines, it’s like manna from heaven. And that’s precisely what happened last week at the annual
What Dentistry Is Teaching Healthcare About Operational AI
Artificial intelligence is rapidly becoming embedded across healthcare, from clinical documentation to diagnostic support. But as organizations move beyond pilot programs, a structural challenge is emerging: AI is only as
AMA Calls on Congress to Improve Safeguards for AI Mental Health Chatbots
As AI chatbots become more popular in mental healthcare, the American Medical Association is urging Congress to strengthen safeguards. The organization sent letters to the Congressional Artificial Intelligence Caucus, the
Why Some Hospitals Are Betting on Midstream Health to Help Eliminate Waste
There are plenty of AI startups on the market promising to bolster hospitals’ finances by increasing revenue. But that’s not the case for San Francisco-based Midstream Health. For most health
Novartis Antimalarial Clears Key WHO Review to Get the Combo Drug to Babies
The first antimalarial developed specifically for babies is a step closer to reaching parts of the world where malaria is endemic. The World Health Organization has completed its review of
The Brand-Driven Flywheel: Igniting Growth Through a Simple Patient Experience
Legacy patient support is no longer fit for purpose. For too long, fragmented manual systems have created data silos and delays, leading to lower adherence rates and refills, decreased patient
Precision Delivered: How Radiopharmaceuticals Are Reshaping Cancer Care
Oncology remains one of the most innovative and rapidly advancing fields in medicine. From chemotherapy to immunotherapy to the rise of personalized treatment, each breakthrough has brought us closer to
Beyond the Scale: How Imaging Can Help Determine GLP-1 Efficacy
The GLP-1 craze is undeniable, with advertising for the injectables flooding our screens and public spaces, restaurants offering GLP-1-friendly menus, and providers restructuring care models around their use. About 12%
VC Firm Kurma Partners Closes €215M Fund in Pursuit of ‘Disruptive Therapeutic Solutions’
Biotechnology-focused venture capital firm Kurma Partners has closed a new fund with €215 million (about $252 million) in fresh capital to deploy across up to 20 young companies in the









